[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343764-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343764-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nationwide-registry-based-trial-of-risk-stratified-cervical-screening-abstract","Nationwide registry-based trial of risk-stratified cervical screening - Abstract","","In well-screened populations, most cervical cancers originate from small groups with inadequate screening. This study evaluates whether registry-based cancer risk assessment can intensify screening for high-risk women. From Sweden’s National Cervical Screening Registry, 28,689 women were invited via SMS and/or letters to order free HPV self-sampling kits. Test processing included extended HPV genotyping and referral for high-risk HPV-positive women. Participation was modest, yet high-risk targeting produced a high yield of CIN2+ and severe HSIL+ among biopsied referrals, with repeat invitations adding limited gains.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nationwide-registry-based-trial-of-risk-stratified-cervical-screening-abstract/343764/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nationwide-registry-based-trial-of-risk-stratified-cervical-screening-abstract/343764.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about cervical screening?","Question",{"text":63,"@type":64},"It assesses whether registry-based cancer risk assessment can be used to increase screening intensity among high-risk women.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants recruited and tested in the nationwide trial?",{"text":68,"@type":64},"The study identified 28,689 women in Sweden with no prior screening or screening history indicating high risk, then invited them via SMS and/or letters to order free HPV self-sampling kits.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the yield of detected disease among referred high-risk HPV-positive women?",{"text":72,"@type":64},"High-risk HPV-positive women were referred without further triaging, and severe cervical precancer or cancer (HSIL+) in histopathology was detected in 36/158 (23%) of biopsied women.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343764,1790638158,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","DOI: 10.1002/ijc.35142  \nRES EARCH A RTICLE  \nCancer Therapy a nd Prevention  \nNationwide registry-based trial of risk-stratified cervical screening  \nLaila Sara Arroyo Mühr 1  | Jiangrong Wang 1  | Sadaf S. Hassan 1 | Emel Yilmaz 1 | Miriam K. Elfström 1,2  | Joakim Dillner 1,2   \n1Center for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden  \n2Center for Cervical Cancer Elimination, Karolinska University Hospital Huddinge, Stockholm, Sweden  \nCorrespondence  \nJoakim Dillner, Center for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14186, Sweden.  \nEmail: [joakim.dillner@ki.se](joakim.dillner@ki.se)  \nFunding information  \nEuropean Union's H2020, Grant/Award Number: 847845  \nAbstract  \nIn well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. The present study aims to assess whether registry-based cancer risk assessment could be used to increase screening intensity among high-risk women. The National Cervical Screening Registry identified the 28,689 women residents in Sweden who had either no previous cervical screening ora screening history indicating high risk. We invited these women by SMS and/or physical letter to order a free human papillomavirus (HPV) self-sampling kit. The Swedish national HPV reference laboratory performed extended HPV genotyping and referred high-risk HPV-positive women to their regional gynecologist. A total of 3691/28,689 (12.9%) women ordered a self-sampling kit and 10.0%(2853/28,689) returned a sample for testing. Participation among women who had never attended screening was low, albeit improved. Up to 22 . 5% of women in other high-risk groups attended. High-risk HPV types were detected in 8 .3% of samples. High-risk HPVpositive women (238/2853) were referred without further triaging and severe cervical precancer or cancer (HSIL+) in histopathology were detected in 36/158 (23%) of biopsied women. Repeat invitations gave modest additional participation. Nationwide contacting of women with high risk for cervical cancer with personal invitations to order HPV self-sampling kits resulted in high yield of detected CIN2+ . Further efforts to improve risk-stratified screening strategies should be directed to improving (i) the precision of the risk-stratification algorithm, (ii) the convenience for the women to participate and,(iii) ensuring that screen-positive women are followed-up.  \nKEYWOR DS  \ncancer risk, cervical cancer elimination, cervical screening, HPV, risk-stratified screening  \nWhat's new?  \nIn generally well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. This proof-of-concept study explored registry-based cancer risk assessment for optimizing screening intensity among high-risk women. Individual cancer risks differed by >1000 times and \u003C1% of women had high cancer risks. The 28,689 women in  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s) . International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.  \nSweden who had either no previous cervical screening results or a screening history indicating high risk were offered self-sampling for human papillomavirus testing. The additional screening yielded a high positive predictive value (23%) for cervical pre-cancer (HSIL+) among biopsied women, suggesting successful targeting of high-risk women.  \n1 | INTRODUCTION  \nPopulation-based human papillomavirus (HPV) screening is a pillar of the global strategy for elimination of cervical cancer.1 Sweden has organized, population-based cervical screening with >80% participation and only a few percent long-term non-atten","cbCaihOVHu4DQUff","https://ap.wps.com/l/cbCaihOVHu4DQUff","pdf",811631,"English","# Abstract\n## Background and purpose\n## Methods and outreach\n## Outcomes and follow-up\n## Conclusion and implications\n# Introduction\n## HPV screening and cervical cancer elimination in Sweden\n## Risk-stratified screening concept and registry determinants\n# Materials and Methods","[{\"question\":\"What question does the study address about cervical screening?\",\"answer\":\"It assesses whether registry-based cancer risk assessment can be used to increase screening intensity among high-risk women.\"},{\"question\":\"How were participants recruited and tested in the nationwide trial?\",\"answer\":\"The study identified 28,689 women in Sweden with no prior screening or screening history indicating high risk, then invited them via SMS and/or letters to order free HPV self-sampling kits.\"},{\"question\":\"What was the yield of detected disease among referred high-risk HPV-positive women?\",\"answer\":\"High-risk HPV-positive women were referred without further triaging, and severe cervical precancer or cancer (HSIL+) in histopathology was detected in 36/158 (23%) of biopsied women.\"}]","Nationwide registry-based trial of risk-stratified cervical screening - Abstract | PDF",1790052044,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/721a8757264a8caed45145acb9e7abe2.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbda6480518cba8ed8e5a61f919945e3.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68be74a60351e55af02f5c476744a79b.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e15a9397c6033c22c84585345728c48b.webp",980,1287]